title: Challenges in DNA microarray studies from the regulatory perspective.
abstract: Genomic classifiers using DNA microarrays are becoming powerful tools in the medical community with the potential to revolutionize the diagnosis and treatment of disease. However, despite the tremendous interest in using these classifiers in diagnosis and the management of disease, few genomic classifiers have made it into clinical practice. Some of the major challenges for the development and validation of genomic classifiers will be discussed in this article together with some of their difficulties.
authors.affiliation: CDRH, U.S. Food and Drug Administration, Rockville, Maryland 20850, USA. samir.lababidi@fda.hhs.gov
authors.forename: Samir
authors.initials: S
authors.lastname: Lababidi
mesh_terms: D020411:Oligonucleotide Array Sequence Analysis / Q000145:classification* / Q000592:standards*; D015203:Reproducibility of Results